New listings in both the Pharmaceutical Schedule Section B and Section H (HML) from 1 April 2017.
Leflunomide-Apo Tab 10 mg 30 Pharmacode 2511843 and Leflunomide-Apo Tab 20 mg 30 Pharmacode 2511851 listing 1 April 2017 and will have HSS status from 1 June 2017 and CSS status from 1 September 2017.
Margins are tight and to make a switch immediately may not be in your best interest.
Sanofi have put in place a 15% discount on all purchases of Arava Tablets until 1 June 2017. This is your opportunity to obtain additional margin on product you can continue to dispense, but manage well.
Arava Tab 10 mg 30 Pharmacode 306843 has an ex-manufacturer price of $55.00 until 1 June 2017 margin on product is $1.65 plus $8.25 discount.
Leflunomide-Apo Tab 10 mg 30 Pharmacode 2511843 has an ex-manufacturer price of $2.90 from 1 June 2017 margin on product is $0.087c.
Arava Tab 20 mg 30 Pharmacode 369470 has an ex-manufacturer price of $76.00 until 1 June 2017 margin on product is $2.28 plus $11.40 discount.
Leflunomide-Apo Tab 20 mg 30 Pharmacode 2511851 has an ex-manufacturer price of $2.90 from 1 June 2017 margin on product is $0.087c.
We all need to make the best of what we have, therefore until stocks are depleted or 1 June 2017 when reference pricing will be applied, continue on as you are. You know you usage so can benefit without risk.
Manage stock very carefully as we will not accept Arava back for credit under any circumstances.
We can confirm that Sanofi are not reducing their price therefore No Price Support. You must manage your stock carefully. ProPharma will act accordingly.